Digipath’s GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide
BOULDER, CO, August 14, 2019 – Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially…